(Q81045137)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Boos CJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Lip GY

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

855-859

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094406%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001933

5 January 2020

exact match

0 references

cites work

Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Hypertension and the prothrombotic state

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Does atrial fibrillation confer a hypercoagulable state?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Evidence for electrical remodelling of the atrial myocardium in patients with atrial fibrillation. A study using the monophasic action potential recording technique

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Electrical remodelling of chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Structural correlate of atrial fibrillation in human patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Angiotensin AT1/AT2 receptors: regulation, signalling and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Renin-angiotensin system gene polymorphisms and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

The antiarrhythmic potential of angiotensin II antagonism: experience with losartan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021

Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001933

7 January 2021